Resorcinol / sulfur topical Pregnancy and Breastfeeding Warnings
Resorcinol / sulfur topical is also known as: Acnomel, Acnotex, Bensulfoid, Rezamid, Sulforcin
Resorcinol / sulfur topical Pregnancy Warnings
Animal studies have not been reported. There are no controlled data in human pregnancy.
The manufacturer makes no recommendation regarding use during pregnancy.
AU TGA pregnancy category: Not formally assigned to a pregnancy category.
US FDA pregnancy category: Not formally assigned to a pregnancy category.
Resorcinol / sulfur topical Breastfeeding Warnings
The manufacturer makes no recommendation regarding use during lactation.
Excreted into human milk: Data not available
Excreted into animal milk: Data not available
Comments:
-The effects in the nursing infant are unknown.
-LactMed: Sulfur 5% to 10% in a petrolatum base is considered safe for topical use in children (including infants younger than 2 months).
See Also...
References for pregnancy information
- "Product Information. Bensulfoid (resorcinol-sulfur topical)." ECR Pharmaceuticals, Richmond, VA.
References for breastfeeding information
- United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
- "Product Information. Bensulfoid (resorcinol-sulfur topical)." ECR Pharmaceuticals, Richmond, VA.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.